share_log

Kezar Life Sciences Q3 EPS $(0.32) Beats $(0.35) Estimate, Sales $7.00K

Moomoo 24/7 ·  Nov 13, 2023 17:14

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.35) by 8.57 percent. This is a 28 percent decrease over losses of $(0.25) per share from the same period last year. The company reported $7.00 thousand in sales this quarter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment